Literature DB >> 3416277

Mortality from papillary thyroid carcinoma. A case-control study of 56 lethal cases.

S A Smith1, I D Hay, J R Goellner, J J Ryan, W M McConahey.   

Abstract

To document the presentation, findings, therapy, and postoperative course of lethal papillary thyroid carcinoma (PTC), 56 fatal cases were studied in a retrospective case-matched control fashion. These patients and their controls were taken from a larger series receiving their primary treatment at one institution (Mayo Clinic; 1946-1970). Mean follow-up for the lethal cohort was 8.5 years and 16.6 years for controls. Age, sex, tumor size, histologic grade, extent of disease at presentation, European Organization for Research on Treatment of Cancer (EORTC) and AGES scores (patient's age, tumor grade, tumor extent, and tumor size), and DNA ploidy pattern were found to be significant prognostic factors. The immediate causes of death were most frequently either local airway obstruction or respiratory insufficiency from pulmonary metastases. The results suggest that it is possible, at the time of initial treatment, to assess an individual patient's risk of dying from PTC. Aggressive postoperative adjunctive therapy should be restricted to that minority of patients who are at highest risk of death from PTC.

Entities:  

Mesh:

Year:  1988        PMID: 3416277     DOI: 10.1002/1097-0142(19881001)62:7<1381::aid-cncr2820620724>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

Review 1.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

Review 2.  Management of Invasive Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Ricard Simo; Kate Newbold; Alessandra Rinaldo; Carlos Suarez; Luiz P Kowalski; Carl Silver; Jatin P Shah; Alfio Ferlito
Journal:  Thyroid       Date:  2016-08-23       Impact factor: 6.568

3.  Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.

Authors:  Bin Xu; Tihana Ibrahimpasic; Laura Wang; Mona M Sabra; Jocelyn C Migliacci; R Michael Tuttle; Ian Ganly; Ronald Ghossein
Journal:  Thyroid       Date:  2016-09-07       Impact factor: 6.568

4.  Surgical treatment for multinodular goitres in geriatric patients.

Authors:  Antonio Ríos; José Manuel Rodríguez; Pedro José Galindo; Manuel Canteras; Pascual Parrilla
Journal:  Langenbecks Arch Surg       Date:  2005-01-15       Impact factor: 3.445

5.  [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].

Authors:  A Larena; M Vierbuchen; S Schröder; A Larena-Avellaneda; I Hadshiew; R Fischer
Journal:  Langenbecks Arch Chir       Date:  1996

Review 6.  The clinician and the thyroid.

Authors:  H J Biersack; A Hotze
Journal:  Eur J Nucl Med       Date:  1991

7.  Management of intracranial metastases of differentiated carcinoma of thyroid.

Authors:  B M Biswal; C S Bal; M S Sandhu; A K Padhy; G K Rath
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Acute respiratory failure in a rapidly enlarging benign cervical goitre.

Authors:  Carlo Jan Garingarao; Cecille Añonuevo-Cruz; Ryan Gasacao
Journal:  BMJ Case Rep       Date:  2013-07-22

9.  Thyroid surgery in the elderly: a comparative experience of 400 patients from an Italian university hospital.

Authors:  Silvestro Canonico; Gianluca Pellino; Domenico Pameggiani; Guido Sciaudone; Giuseppe Candilio; G Serena De Fatico; Isabella Landino; Rosa Marcellinaro; Federica Rocco; Lucio Selvaggi; Umberto Parmeggiani; Francesco Selvaggi
Journal:  Int Surg       Date:  2014 Sep-Oct

10.  Prognostic factors in patients with multiple recurrences of well-differentiated thyroid carcinoma.

Authors:  Theresa Holler; Jenna Theriault; Richard J Payne; Jonathan Clark; Spiro Eski; Jeremy L Freeman
Journal:  J Oncol       Date:  2009-10-15       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.